Pyrrolo[1,2-f][1,2,4]triazin-4-amine/159326-68-8

Usage: Remdesivir intermediate (development code GS-5734) is a novel antiviral drug in the class of nucleotide analogs, used in treatment of COVID-19.
Chemical Name: 4-AMino-pyrrolo[2,1-f][1,2,4]triazin;4-AMinopyrrolo[2,1-f][1,2,4]triazine;Pyrrolo[2,1-f][1,2,4]triazin-4-aMin;4-pyrrolo[2,1-f][1,2,4]triazinamine
CAS No.: 159326-68-8

Product Details

Product Name:pyrrolo[1,2-f][1,2,4]triazin-4-amine

Usage: Remdesivir intermediate (development code GS-5734) is a novel antiviral drug in the class of nucleotide analogs, used in treatment of COVID-19.

Chemical Name: 4-AMino-pyrrolo[2,1-f][1,2,4]triazin;4-AMinopyrrolo[2,1-f][1,2,4]triazine;Pyrrolo[2,1-f][1,2,4]triazin-4-aMin;4-pyrrolo[2,1-f][1,2,4]triazinamine

CAS No.: 159326-68-8


Molecular Formula: C6H6N4
Molecular Weight: 134.6


Specifications: 

Appearance: Yellow to brown solid;

Purity: 98.0%min

Based on success against other coronavirus infections, Gilead provided remdesivir to physicians who treated an American patient in Snohomish County, Washington in 2020, infected with SARS-CoV-2 and is providing the compound to China to conduct a pair of trials in infected individuals with and without severe symptoms.


Inquiry